ICU

SeaStar Medical Holding Corp

3.21

Oct 07 • 1:39 PM ET +0.02 (0.63%)

Healthcare Biotechnology USA Nano NASD

Today, 8:50 AMSeaStar Medical gets FDA Breakthrough Device Designation for SCD therapy in adult patients with sepsis

Peers: BLRX GDTC GTBP INTS KRSA TOVX BIVI ERNA GNTA MBRX

| Held by: VXF DXUV DFAC

Scroll to Statements

Index	-
Market Cap	14.15M
Enterprise Value	7.32M
Income	-13.63M
Sales	1.71M
Book/sh	1.01
Cash/sh	1.58
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	17
IPO	Mar 18, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	8.27
P/B	3.18
P/C	2.03
P/FCF	-
EV/EBITDA	-
EV/Sales	4.28
Quick Ratio	1.87
Current Ratio	1.89
Debt/Eq	0.03
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-3.93
EPS next Y	-2.09
EPS next Q	-0.95
EPS this Y	37.54%
EPS next Y	42.90%
EPS next 5Y	49.38%
EPS past 3/5Y	74.91% -125.73%
Sales past 3/5Y	- -
EPS Y/Y TTM	83.96%
Sales Y/Y TTM	123.63%
EPS Q/Q	48.32%
Sales Q/Q	81.95%
Earnings	Aug 12 AMC
EPS/Sales Surpr.	6.19% 26.41%

Insider Own	3.10%
Insider Trans	0.55%
Inst Own	3.86%
Inst Trans	1.31%
ROA	-160.02%
ROE	-356.87%
ROIC	-317.20%
Gross Margin	92.64%
Oper. Margin	-816.64%
Profit Margin	-795.50%
SMA20	-7.17%
SMA50	-2.56%
SMA200	-2.28%
Trades

Shs Outstand	4.41M
Shs Float	4.27M
Short Float	2.85%
Short Ratio	1.53
Short Interest	0.12M
52W High	7.35 -56.33%
52W Low	2.07 55.07%
Volatility	14.73% 8.82%
ATR (14)	0.41
RSI (14)	45.95
Beta	-1.13
Rel Volume	21.61
Avg Volume	79.72K
Volume	1,130,846

Perf Week	-18.53%
Perf Month	8.81%
Perf Quarter	-34.49%
Perf Half Y	-23.21%
Perf YTD	33.75%
Perf Year	-50.02%
Perf 3Y	-97.60%
Perf 5Y	-99.87%
Perf 10Y	-
Recom	1.00
Target Price	12.00
Prev Close	3.19
Price	3.21
Change %	0.63%

Today 08:16AM	FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition (GlobeNewswire)
Oct-05-26 08:00AM	SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds (GlobeNewswire) -24.31%
Oct-02-26 09:43AM	SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026 (GlobeNewswire) +25.07%
Oct-01-26 08:21AM	New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical's SCD Therapy for Acute Kidney Injury (AKI) (GlobeNewswire)
Sep-29-26 08:36AM	SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026 (GlobeNewswire)
08:16AM	Loading…
Sep-24-26 08:16AM	SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy (GlobeNewswire)
Sep-10-26 08:35AM	SeaStar Medical to Present at the HC Wainwright 28th Annual Global Investment Conference (GlobeNewswire)
Aug-13-26 01:02AM	SeaStar Medical Holding Corp (ICU) (Q2 2026) Earnings Call Highlights: Qualimmune Revenue ... (GuruFocus.com) -5.65%
Aug-12-26 04:05PM	SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates (GlobeNewswire) -8.94%
Aug-11-26 09:29AM	SeaStar Medical Holding Corp (ICU) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-06-26 08:35AM	SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 (GlobeNewswire)
Jul-14-26 08:34AM	SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI) (GlobeNewswire)
Jun-23-26 08:25AM	SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury (GlobeNewswire) +7.10%
Jun-22-26 08:45AM	SeaStar Medical to Present at Upcoming Investor Summit Conference (GlobeNewswire)
May-14-26 08:30AM	SeaStar Medical Holding Corporation Q2 2026 Earnings Call Summary (Moby) -8.70%
01:01AM	Loading…
01:01AM	SeaStar Medical Holding Corp (ICU) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-13-26 04:05PM	SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates (GlobeNewswire)
May-06-26 08:20AM	SeaStar Medical to Report First Quarter Financial Results on May 13, 2026 (GlobeNewswire) +10.18%
Mar-30-26 08:20AM	SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026 (GlobeNewswire) +32.12%
Mar-25-26 11:01PM	SeaStar Medical Holding Corp (ICU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +22.37%
04:05PM	SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-18-26 04:05PM	SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026 (GlobeNewswire) -5.24%
Mar-05-26 08:20AM	SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI (GlobeNewswire)
Feb-09-26 08:20AM	SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI) (GlobeNewswire)
Jan-29-26 08:25AM	SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference (GlobeNewswire)
Jan-07-26 08:13AM	SeaStar Medical Announces 2026 Milestones (GlobeNewswire)
Jan-06-26 08:53AM	SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference (GlobeNewswire)
Dec-23-25 04:25PM	SeaStar Medical Announces 1-for-10 Reverse Split (GlobeNewswire) -8.59%
Dec-02-25 08:27AM	SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI (GlobeNewswire) +8.28%
Nov-20-25 09:52AM	SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference (GlobeNewswire)
08:43AM	Loading…
Nov-17-25 08:43AM	SeaStar Medical Announces Appointment of Michael Messinger as CFO (GlobeNewswire) -20.26%
Nov-14-25 12:04AM	SeaStar Medical Holding Corp (ICU) Q3 2025 Earnings Call Highlights: Revenue Surge and ... (GuruFocus.com) -17.39%
Nov-13-25 04:05PM	SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire) -7.85%
Nov-05-25 10:03AM	SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025 (GlobeNewswire)
Sep-29-25 08:36AM	SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children (GlobeNewswire)
Sep-24-25 04:22PM	SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury (GlobeNewswire) +6.90% -50.94%
Sep-23-25 08:23AM	SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children (GlobeNewswire) +16.00%
Sep-04-25 06:13PM	SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference (GlobeNewswire) -5.21%
Sep-02-25 08:22AM	SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival (GlobeNewswire)
Aug-14-25 03:14AM	SeaStar Medical Holding Corp (ICU) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) +20.98%
Aug-13-25 04:05PM	SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-07-25 10:00AM	SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025 (GlobeNewswire)
Aug-06-25 08:33AM	SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI) (GlobeNewswire) +7.03%
Jul-31-25 03:01PM	SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -22.37%
Jul-22-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +12.53%
08:20AM	SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients (GlobeNewswire)
Jul-16-25 08:45AM	SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry (GlobeNewswire) +9.18%
Jul-10-25 03:29PM	SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -14.15%
Jul-08-25 08:05AM	SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI) (GlobeNewswire) +47.62%
Jul-02-25 04:25PM	SeaStar Medical Announces Positive Nasdaq Listing Determination (GlobeNewswire) +15.46%
Jun-25-25 08:05AM	SeaStar Medical Reports Update on Nasdaq Listing Status (GlobeNewswire) +17.63%
Jun-24-25 09:05AM	SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy (GlobeNewswire) +8.35%
Jun-20-25 12:10PM	SeaStar Medical Announces Pricing of Up to $8 Million Public Offering (GlobeNewswire) -63.89%
Jun-11-25 08:25AM	AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research (GlobeNewswire)
May-29-25 10:13AM	SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market (NewMediaWire)
May-28-25 08:05AM	SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy (GlobeNewswire)
May-14-25 04:05PM	SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates (GlobeNewswire)
May-13-25 08:05AM	SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (GlobeNewswire)
May-07-25 10:00AM	SeaStar Medical to Report First Quarter Financial Results on May 14, 2025 (GlobeNewswire)
Apr-30-25 08:05AM	SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time (GlobeNewswire)
Apr-08-25 08:05AM	FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery (GlobeNewswire) -6.72%
Mar-27-25 04:05PM	SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates (GlobeNewswire) -9.47% -22.73%
Mar-24-25 05:30PM	SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025 (GlobeNewswire)
Mar-18-25 08:45AM	NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award (PR Newswire)
Feb-03-25 04:05PM	SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market (GlobeNewswire) -16.23%
Jan-31-25 08:00AM	SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market (GlobeNewswire) +29.48%
Jan-27-25 08:00AM	SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE (GlobeNewswire)
Jan-22-25 07:30AM	SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial (GlobeNewswire) -5.71%
Jan-14-25 08:35AM	SeaStar Medical says FDA approves feasibility study with SCD-ADULT (TipRanks)
Jan-13-25 08:30AM	FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome (GlobeNewswire)
Jan-08-25 08:30AM	SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer (GlobeNewswire)
Dec-23-24 07:00AM	SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial (GlobeNewswire)
Dec-11-24 06:30AM	SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications (GlobeNewswire) -7.11%
Dec-04-24 08:30AM	SeaStar Medical to Hold Business Update Conference Call on December 11, 2024 (GlobeNewswire) +7.17%
Dec-03-24 08:30AM	SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial (GlobeNewswire)
Nov-26-24 08:00AM	SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024 (GlobeNewswire) +7.98%
Nov-22-24 08:30AM	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares (GlobeNewswire) -6.82%
Nov-15-24 08:30AM	SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer (GlobeNewswire) +11.73%
Nov-13-24 05:05PM	SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire) -5.62% -22.22%
Nov-06-24 09:00AM	FDA Grants Breakthrough Device Designation for SeaStar Medical's Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis (GlobeNewswire)
Nov-01-24 08:30AM	Record Monthly Enrollment Achieved in SeaStar Medical's Pivotal Adult AKI Trial (GlobeNewswire)
Oct-31-24 08:30AM	SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE (GlobeNewswire)
Oct-25-24 11:32AM	Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 - Update (GlobeNewswire)
08:30AM	Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical's QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024 (GlobeNewswire)
Oct-23-24 08:30AM	SeaStar Medical Announces that Stanford Medicine is Cleared to Actively Enroll Subjects in the Adult Acute Kidney Injury Pivotal Trial (GlobeNewswire) -5.19%
Oct-22-24 08:30AM	SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers (GlobeNewswire)
Oct-18-24 08:30AM	SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis (GlobeNewswire)
Oct-15-24 08:30AM	SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week (GlobeNewswire)
Oct-09-24 08:30AM	SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire)
Oct-08-24 08:30AM	SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities (GlobeNewswire)
Sep-25-24 08:30AM	SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial (GlobeNewswire) -6.26%
Sep-05-24 08:00AM	SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference (GlobeNewswire) -5.14%
Sep-04-24 08:30AM	SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt (GlobeNewswire) +7.36%
Aug-23-24 05:45AM	SeaStar Medical Holding Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your Rights - ICU (PR Newswire)
Aug-13-24 04:38PM	SeaStar Medical Reports Second Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire) -16.51% -17.46%
Aug-08-24 12:38PM	SeaStar Medical Holding Corporation Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your Rights ICU (GlobeNewswire)
Jul-26-24 09:00AM	Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE Therapy at Cincinnati Children's (GlobeNewswire) +11.53%
Jul-23-24 08:30AM	First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's FDA-Approved QUELIMMUNE Therapeutic Device (GlobeNewswire) +9.78%
Jul-17-24 09:00AM	Nuwellis Marks First Commercial Sale of QUELIMMUNE Therapy to Cincinnati Children's (GlobeNewswire)
Jul-16-24 08:30AM	CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical's Selective Cytopheretic Device Pivotal Trial (GlobeNewswire) +6.71%

Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company was founded on June 6, 2007 and is headquartered in Denver, CO.

CEOMr. Eric Schlorff

Chief Financial OfficerMr. Michael Messinger CPA

M.D.Colonel Kevin Chung FACP

Co-Founder & Scientific AdvisorDr. H. David Humes M.D.

Vice President of Operations & Product DevelopmentMr. Tom Mullen

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Messinger Michael	Chief Financial Officer	Aug 18 '26	Buy	3.27	750	2,452	2,500	Aug 19 04:21 PM
Baird Jennifer A	Director	Dec 19 '25	Buy	0.24	4,200	987	36,200	Dec 22 06:55 PM
Messinger Michael	Chief Financial Officer	Dec 09 '25	Buy	0.35	14,500	5,098	17,500	Dec 11 06:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICU

SeaStar Medical Holding Corp

Upgrade your Finviz experience